Global Parenteral Nutrition Market Report and Forecast 2024-2032

Global Parenteral Nutrition Market Outlook

The global parenteral nutrition market size reached a value of nearly USD 6.74 billion in 2023. The market is assessed to grow at a CAGR of 6.7% between 2024 and 2032, reaching a value of around USD 12.09 billion by 2032.

Key Trends in the Market

Parenteral nutrition, medically referred to as intravenous feeding, is a way to feed the body by injecting nutrients directly into the veins. It is employed when eating or absorbing nutrients through the digestive system is impossible or inappropriate. Parenteral nutrition is widely used during various health issues, including gastrointestinal obstruction, acute pancreatitis, and malabsorption syndrome.

Parenteral nutrition aids in supplying the body with liquid nutrients such as carbohydrates, proteins, lipids, vitamins, minerals, and electrolytes, among others.

• The rising prevalence of various diseases and chronic disorders globally is the primary reason driving the parenteral nutrition market demand. With increasing cases of cancer and Crohn’s disease that can obstruct the bowel and cause inflammation, the demand for parenteral nutrition is expected to increase during the forecast period.

• Home parenteral nutrition (HPN) therapy is gaining popularity in the parenteral nutrition market. HPN enables patients to receive parenteral nutrition in the comfort of their own homes instead of receiving it in a hospital setting, which can enhance their quality of life and lower healthcare expenditures. The market is also being supported by the rising demand for specialised goods and services that support HPN therapy.

• Another market trend driving the parenteral nutrition market expansion is the development of enhanced product formulations. Key players are extensively investing in R&D activities to create novel parenteral nutrition formulations that are tailored to the specific demands of patients.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Opportunities and Challenges in the Market

The rising cases of premature births, especially in developing countries like India, Nigeria, the Philippines, and Indonesia, among others, are significantly propelling the demand for parenteral nutrition. In addition, the increasing incidences of chronic illnesses like cystic fibrosis, congenital heart conditions, and cerebral palsy, among others, are providing lucrative growth opportunities to the parenteral nutrition market.

Prominent market players are placing emphasis on strategic partnerships, new product launches, and strategic alliances for corporate growth. These market participants are also investments in R&D projects and regional expansion strategies to drive advancements in the market for parenteral nutrition.

However, a lack of knowledge about various parenteral nutrition methods, especially in emerging economies, that can improve patient health may limit the market growth. Parenteral nutrition knowledge gaps also lead to nutritional deficiencies, which raise the risk of developing chronic diseases.

Market Analysis

Based on nutrient type, the market can be segmented into carbohydrates, parenteral lipid emulsion, single-dose amino acid solution, trace elements, and vitamins and minerals. By end-use, the market can be divided into hospitals and clinics, among others. The major regional markets for parenteral nutrition  can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global parenteral nutrition market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

• B. Braun SE

• Fresenius Kabi

• GRIFOLS, S.A.

• Baxter International, Inc

• Otsuka Pharmaceutical Factory, Inc.

• Kelun

• Libang HealthCare Group

• Orbisana Healthcare GmbH

• Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The Single-Dose Amino Acid Solution Segment Holds a Considerable Share in the Market for Parenteral Nutrition

Over the forecast period, the single-dose amino acid solution segment is anticipated to significantly contribute to the parenteral nutrition market demand. This can be ascribed to an increase in the use of amino acid solutions to deliver optimal amounts of protein and the surging regulatory approvals of new single-dose amino acid solutions. Moreover, key players are developing single-dose amino acid solutions with fewer side effects to improve patient outcomes. 

Essential and non-essential amino acids are included in mixed amino acid formulations, due to which they serve as comprehensive parenteral nutrition solutions for the body's entire biological function.

Parenteral Nutrition Market Share by Region

North America accounts for a considerable market share. This can be associated with high investments in research activities by healthcare-related private entities and government agencies, the growing availability of technologically advanced medical equipment, and increasing partnerships between medical device companies, regulatory agencies, and universities to advance parenteral nutrition.

Modern healthcare facilities, attractive reimbursement policies, and favourable regulations in the region are favouring the parenteral nutrition market growth. Also, the rising prevalence of numerous chronic diseases, such as cancer, and high hospital admission rates in the United States and Canada are supporting the market demand.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

B. Braun SE, established in 1839, is one of the top providers of medical technology, which works to safeguard and enhance public health throughout the world. The business specialises in a number of medical technology areas, including extracorporeal blood transfusion therapy, degenerative spinal disorders, diabetes care, continence care and urology, and cardio-thoracic surgery.

Fresenius Kabi is a global healthcare corporation that focuses on the development of life-saving drugs and equipment for infusion, transfusion, and therapeutic nutrition. The company’s services and products are utilised for the therapy and care. Fresenius Kabi aims to provide patients and carers access to vital medications and technology while helping them find the best solutions to their problems.

Baxter International, Inc., is a prominent healthcare company, headquartered in Illinois, the United States. The company has been influencing healthcare providers with innovations for 90 years. The company is focusing to develop the next generation of revolutionary healthcare technologies. Its products, medicines, and digital health solutions are accessible in more than 100 countries globally.

Other market players include GRIFOLS, S.A, Otsuka Pharmaceutical Factory, Inc., Kelun, Libang HealthCare Group, and Orbisana Healthcare GmbH, among others.

Key Highlights of the Report